Hack targets Planned Parenthood, exposing personal information of 400K patients
Fierce Healthcare
DECEMBER 3, 2021
Hack targets Planned Parenthood, exposing personal information of 400K patients. rtorrence. Fri, 12/03/2021 - 10:13.
Fierce Healthcare
DECEMBER 3, 2021
Hack targets Planned Parenthood, exposing personal information of 400K patients. rtorrence. Fri, 12/03/2021 - 10:13.
pharmaphorum
DECEMBER 2, 2021
Personalised and tailored healthcare that utilises patient’s data is rapidly becoming a reality. Ben Hargreaves looks at the concrete steps already being taken by companies in the area. Amongst the many ways in which the pandemic has changed the way in which we live, one of the most common experiences for most people was to revise what it means to have a face-to-face meeting.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Outsourcing Pharma
NOVEMBER 29, 2021
A leader from the health tech solutions company explains how progress in genetic testing has helped advance the detection and prevention of breast cancer.
Pharma Times
NOVEMBER 30, 2021
Following its recent approval of an injectable HIV-1 treatment from the National institute for Health and Care Excellence (NICE), GlaxoSmithKline (GSK) has high hopes in developing a cure for the virus in the future.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Fierce Healthcare
DECEMBER 2, 2021
CVS inks tech partnership with Microsoft to accelerate its 'digital-first' strategy. hlandi. Thu, 12/02/2021 - 06:26.
pharmaphorum
NOVEMBER 28, 2021
An investigator-led trial of Jazz Pharma’s cannabis extract-based drug Sativex in glioblastoma – an aggressive form of brain cancer – will get underway in the UK next year. The three-year phase 2 trial will be carried out by researchers at Leeds University led by professor of clinical oncology and neuro-oncology Susan Short, and see if adding Sativex (nabiximols) to standard chemotherapy for recurrent glioblastoma can extend survival.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Times
NOVEMBER 29, 2021
Analyses provided by UK cancer charity Macmillan has provided insights into the repercussions experienced by patients waiting to receive treatment during the COVID-19 pandemic.
Fierce Healthcare
DECEMBER 3, 2021
Out-of-pocket costs may play larger role in telehealth visits than in-person care: survey. rtorrence. Fri, 12/03/2021 - 16:07.
pharmaphorum
DECEMBER 3, 2021
An online training academy that aims to raise the digital skills of NHS health and care workers is due to open its virtual doors next March, according to the Organisation for the Review of Care and Health Apps (ORCHA). The Digital Health Academy – developed with pharma company Boehringer Ingelheim – is part of a drive to get digital health tools and apps used more routinely in the management of health conditions, according to ORCHA.
Outsourcing Pharma
DECEMBER 2, 2021
An expert from the ]contract research organization discusses the impact virtual trials have had on the industry, and how that transformation is likely to continue.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Times
DECEMBER 2, 2021
Researchers have identified in those patients experiencing blood clots after vaccination a subsequent condition referred to as vaccine-induced immune thrombotic thrombocytopenia (VITT).
Fierce Healthcare
NOVEMBER 29, 2021
Business Group: 6 health and wellness trends to watch in 2022. pminemyer. Mon, 11/29/2021 - 12:17.
pharmaphorum
DECEMBER 2, 2021
The UK medicines regulator has approved GlaxoSmithKline and Vir Biotech’s antibody for COVID-19, Xevudy, which has been shown to be effective against the new Omicron strain of SARS-CoV-2 in lab testing. Xevudy (sotrovimab) is the second COVID-19 antibody to be approved by the MHRA after Roche/Regeneron’s Ronapreve (casirivimab and imdevimab), which got a green light during the summer.
Outsourcing Pharma
DECEMBER 2, 2021
The Oxford-GSK Institute of Molecular and Computational Medicine has been created via a five-year collaboration between GlaxoSmithKline and the University of Oxford.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
The Spirit Pharmacist
DECEMBER 2, 2021
Growing Pains and the Access Bottleneck. Psychedelic therapies are making headlines due to the unprecedented benefits demonstrated in clinical trials for persons with refractory mental illnesses. However, psychedelic assisted therapy is resource intensive and will likely come with a price tag putting it out of reach of many persons that could benefit from such therapies.
Fierce Healthcare
DECEMBER 1, 2021
Carbon Health launches new program with continuous glucose monitors to assess diabetes risk. rtorrence. Wed, 12/01/2021 - 17:47.
pharmaphorum
NOVEMBER 30, 2021
The FDA will deliver a verdict on AstraZeneca’s PARP inhibitor Lynparza as an adjuvant treatment for breast cancer in the first quarter of next year, after granting the application a priority review. AZ and partner Merck & Co have filed Lynparza (olaparib) for use in BRCA-mutated, HER2-negative early breast cancer in patients who have already been treated with chemotherapy either before or after surgery and are at high risk of the disease coming back.
Outsourcing Pharma
DECEMBER 1, 2021
An expert from the decentralized clinical trial solutions provider discusses how the virtual format and technology can help improve study representation.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharma Marketing Network
DECEMBER 2, 2021
Tune in to this episode of the Pharma Marketing Podcast to hear from our guest, Robert Schildt, Senior Director of Go-To-Market Innovation at Biohaven Pharmaceuticals and Jennifer Ginest, Digital Marketing Manager of PMN discuss how digital is being used to engage and personalize the CX experience in pharma.
Fierce Healthcare
DECEMBER 3, 2021
Pandemic-era burnout, short-staffing has more nurses eyeing the door, survey says. dmuoio. Fri, 12/03/2021 - 14:22.
pharmaphorum
DECEMBER 2, 2021
Novartis has licensed a potential drug for Parkinson’s from Belgium’s UCB that it thinks could be the first oral, disease-modifying drug for the disease – if it can avoid the fate of earlier drugs in the class. The drug – called UCB0599 – targets a protein called alpha synuclein that tends to get misfolded and accumulates into clumps in the brains of Parkinson’s patients, and is thought to damage neurons – somewhat analogous to amyloid and tau proteins in Alzheimer’s dise
Outsourcing Pharma
DECEMBER 1, 2021
With the release of its new Sight OLO artificial intelligence based blood analyzer, Sight Diagnostics hopes to offer DCTs reliable, easy-to-use testing.
Fuld
DECEMBER 2, 2021
Why is market intelligence important? Market intelligence is important for any company – whether that company is seeking growth or just working to maintain share. Markets are dynamic and any number of asymmetric and unknown forces can be at play. Typically, clients are looking for market insight when they are about to make an investment, forge a partnership or change their go-to market strategy.
Fierce Healthcare
DECEMBER 3, 2021
AMA: Medicare physician fee schedule spending dropped nearly $14B last year due to COVID-19. rking. Fri, 12/03/2021 - 12:25.
pharmaphorum
NOVEMBER 28, 2021
With governments around the world announcing measures to curb the new B.1.1.529 variant of COVID-19 – now christened Omicron – leading vaccine manufacturers have said they are poised to develop new shots if needed. News of the new variant emerged last week, and has resulted in travel bans being imposed on various African countries by the US, EU and UK, among others.
Outsourcing Pharma
DECEMBER 2, 2021
An expert from the contract research organization discusses the impact decentralized trials have had on the industry, and how that transformation is likely to continue.
Pharmig
DECEMBER 1, 2021
It’s now time for Pharmig to look forward into 2022 and update our event portfolio. The post 2022 membership for microbiologists and those working alongside them appeared first on Pharmig.
Fierce Healthcare
DECEMBER 2, 2021
PCMA pulls lawsuit over rebate disclosure rule after reaching deal with Biden admin. rking. Thu, 12/02/2021 - 16:20.
pharmaphorum
DECEMBER 3, 2021
Bayer’s Nubeqa is making headway as a treatment for castration-resistant prostate cancer (CRPC), but could be on track to expand the eligible patient population for the drug thanks to new phase 3 data. Just released results from the ARASENS trial show that adding Nubeqa (darolutamide) to docetaxel chemotherapy and androgen deprivation therapy (ADT) to switch off testosterone production helps men with castration-sensitive prostate cancer (CSPC).
Outsourcing Pharma
DECEMBER 1, 2021
A leader from the pharmacovigilance solutions firm discusses the ins and outs managing safety documentation and offers advice on how to deal with them.
Pharma Mirror
DECEMBER 1, 2021
Rockville, Emmes today announced that it conducted the data and statistical analysis for the third iteration of the Adaptive COVID-19 Treatment Trial (ACTT-3), using its proprietary Advantage eClinical system. The ACTT-3 trial assessed the efficacy and safety of interferon beta-1a plus remdesivir compared to remdesivir alone in hospitalized adults with COVID-19.
Fierce Healthcare
DECEMBER 3, 2021
HHS: Telehealth use in Medicare increased 63-fold last year with behavioral health increasing the most. rking. Fri, 12/03/2021 - 16:14.
pharmaphorum
DECEMBER 1, 2021
Oliver Stohlmann’s Corporate Survival Hacks series draws on his experiences of working in local, regional and global life science communications to offer some little tips for enjoying a big business career. This post looks at people manager effectiveness and how to boost team and co-worker engagement. It’s that special time in the annual corporate lifecycle: year-end performance reviews are being conducted around the globe, employee ratings allocated, calibrated and translated into salary increa
Let's personalize your content